Serial Number | 90458999 |
Word Mark | GALXC PLUS |
Filing Date | Monday, January 11, 2021 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, March 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 16, 2024 |
Goods and Services | Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies |
Pseudo Mark | GALAXY PLUS |
Goods and Services | Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of disorders outside the liver; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, April 10, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, April 10, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Dicerna Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Lexington, MA 02421 |
Party Name | Dicerna Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Lexington, MA 02421 |
Event Date | Event Description |
Tuesday, March 12, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 16, 2024 | PUBLISHED FOR OPPOSITION |
Wednesday, December 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, December 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, November 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, November 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, November 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, August 10, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, August 10, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Thursday, May 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, May 11, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, May 11, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, April 6, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Tuesday, February 7, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, February 7, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, February 7, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, September 7, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Wednesday, May 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, May 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, May 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, March 7, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Wednesday, February 2, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, February 2, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, February 2, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, January 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, January 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, January 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, January 5, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, January 5, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, January 5, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, January 5, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, January 5, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, August 31, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, August 31, 2021 | LETTER OF SUSPENSION E-MAILED |
Tuesday, August 31, 2021 | SUSPENSION LETTER WRITTEN |
Thursday, August 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, August 12, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, August 12, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, July 27, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, July 27, 2021 | NON-FINAL ACTION E-MAILED |
Tuesday, July 27, 2021 | NON-FINAL ACTION WRITTEN |
Tuesday, July 20, 2021 | ASSIGNED TO EXAMINER |
Saturday, April 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, February 25, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, February 25, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, February 25, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, January 19, 2021 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Tuesday, January 19, 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Thursday, January 14, 2021 | NEW APPLICATION ENTERED |